Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2265|83|6|812-819

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.83, Iss.6, 2015-12, pp. : 812-819

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin resistance in patients with polycystic ovary syndrome

By Schröder Annika   Tauchert Sascha   Ortmann Olaf   Diedrich Klaus   Weiss Jürgen  

Annals of Medicine, Vol. 36, Iss. 6, 2004-10 ,pp. : 426-439

Informa Healthcare

Access to resources Recommend Favorite

Polycystic ovary syndrome: is obesity a symptom?

By Yildiz Bulent O  

Women's Health, Vol. 9, Iss. 6, 2013-11 ,pp. : 505-507

Future Medicine

Access to resources Recommend Favorite

Obesity management in women with polycystic ovary syndrome

By Lim Siew S   Clifton Peter M   Noakes Manny   Norman Robert J  

Women's Health, Vol. 3, Iss. 1, 2007-01 ,pp. : 73-86

Future Medicine

Access to resources Recommend Favorite

The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome

By Mellati Ali Awsat   Sharifi Faranak   Sajadinejad Mohsen   Sohrabi Davood   Mazloomzadeh Saeideh  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 1, 2012-02 ,pp. : 39-44

Informa Healthcare

Access to resources Recommend Favorite

Effects of Insulin Resistance on Myocardial Blood Flow and Arterial Peripheral Circulation in Patients with Polycystic Ovary Syndrome

By  

ECHOCARDIOGRAPHY (ELECTRONIC), Vol. 32, Iss. 8, 2015-08 ,pp. : 1277-1284

John Wiley & Sons Inc

Access to resources Recommend Favorite